Gregory O. Anglum is CLO & VP at Bioventus Inc. (BVS). They have made 1 open-market trade across 1 company since 2021, most recently 2022-02-14.
CIK 0001680271
1 open-market purchase totalling $78K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BVS | 56,307 | $749K |
Shares reported on the most recent Form 4, priced at the 2022-02-15 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.